Rulide: Advanced Macrolide Antibiotic for Effective Bacterial Eradication
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.89 | $53.32 (0%) | 🛒 Add to cart |
| 90 | $0.81 | $79.98 $73.10 (9%) | 🛒 Add to cart |
| 120 | $0.75 | $106.64 $90.30 (15%) | 🛒 Add to cart |
| 180 | $0.68 | $159.96 $122.98 (23%) | 🛒 Add to cart |
| 270 | $0.61 | $239.94 $164.26 (32%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $319.92 $209.84 (34%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $1.98 | $39.56 (0%) | 🛒 Add to cart |
| 30 | $1.89 | $59.34 $56.76 (4%) | 🛒 Add to cart |
| 60 | $1.72 | $118.68 $103.20 (13%) | 🛒 Add to cart |
| 90 | $1.55 | $178.02 $139.32 (22%) | 🛒 Add to cart |
| 120 | $1.38 | $237.36 $165.12 (30%) | 🛒 Add to cart |
| 180 | $1.20 | $356.04 $216.72 (39%) | 🛒 Add to cart |
| 270 | $1.03 | $534.06 $278.64 (48%) | 🛒 Add to cart |
| 360 | $0.95
Best per pill | $712.08 $340.56 (52%) | 🛒 Add to cart |
Synonyms | |||
Rulide (roxithromycin) is a semi-synthetic macrolide antibiotic designed for the targeted treatment of a wide spectrum of bacterial infections. It operates by inhibiting bacterial protein synthesis, effectively halting the growth and proliferation of susceptible pathogens. With its enhanced pharmacokinetic profile, including superior tissue penetration and an extended half-life, Rulide offers clinicians a potent therapeutic option for respiratory, skin, and soft tissue infections. Its well-established efficacy and favorable tolerability profile make it a cornerstone in outpatient antimicrobial therapy.
Features
- Active Ingredient: Roxithromycin 150 mg or 300 mg film-coated tablets
- Pharmacological Class: Macrolide antibiotic
- Mechanism of Action: Binds to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis
- Bioavailability: Approximately 50%, not significantly affected by food intake
- Half-Life: 12 hours, allowing for convenient twice-daily dosing
- Excretion: Primarily hepatic, via bile and feces; minimal renal excretion
Benefits
- Broad-Spectrum Efficacy: Effective against Gram-positive bacteria, some Gram-negative organisms, and atypical pathogens like Chlamydia, Mycoplasma, and Legionella species.
- Convenient Dosing Regimen: Twice-daily administration supports patient adherence and simplifies treatment protocols.
- Superior Tissue Penetration: Achieves high concentrations at the site of infection, particularly in respiratory tissues, tonsils, and skin.
- Favorable Safety Profile: Generally well-tolerated, with a lower incidence of severe gastrointestinal disturbances compared to earlier macrolides.
- Outpatient Management: Enables effective treatment of moderate infections without requiring hospitalization.
- Proven Clinical Track Record: Extensively studied and widely prescribed globally with consistent therapeutic outcomes.
Common use
Rulide is indicated for the treatment of bacterial infections caused by susceptible microorganisms. Its primary applications include:
- Upper and lower respiratory tract infections: pharyngitis, tonsillitis, acute bronchitis, community-acquired pneumonia, and acute sinusitis.
- Skin and soft tissue infections: erysipelas, impetigo, and secondary infected dermatoses.
- Genitourinary infections: non-gonococcal urethritis and cervicitis caused by Chlamydia trachomatis.
- Dental infections: such as acute odontogenic infections.
It is not effective against viral infections, and its use should be reserved for confirmed or strongly suspected bacterial etiologies to minimize antimicrobial resistance.
Dosage and direction
The standard adult dosage is 300 mg daily, administered as either 150 mg twice daily or 300 mg once daily. For severe infections, the dose may be increased to 300 mg twice daily, though this should be guided by clinical severity and patient tolerance.
For children, the dosage is weight-based: 2.5–5 mg/kg twice daily, not exceeding the adult dose. Tablets should be swallowed whole with a glass of water and can be taken with or without food, though administration with food may reduce the risk of gastrointestinal discomfort.
The typical duration of therapy is 5 to 10 days, depending on the infection type and clinical response. Treatment should continue for at least 48 hours after symptoms resolve to ensure eradication.
Precautions
- Hepatic impairment: Use with caution in patients with liver dysfunction; consider monitoring liver function tests during prolonged therapy.
- Renal impairment: Dosage adjustment is generally not required, but caution is advised in severe renal insufficiency.
- Clostridium difficile-associated diarrhea: Antibiotic use may result in overgrowth of non-susceptible organisms; discontinue if diarrhea develops.
- Prolonged use: May result in superinfection, including fungal or bacterial overgrowth.
- Pregnancy and lactation: Use only if clearly needed; roxithromycin crosses the placenta and is excreted in breast milk.
- Cardiac effects: Macrolides have been associated with QT prolongation; use caution in patients with known arrhythmias or those taking other QT-prolonging drugs.
Contraindications
- Hypersensitivity to roxithromycin, other macrolide antibiotics, or any component of the formulation.
- Concurrent administration with ergot derivatives or terfenadine due to risk of serious adverse reactions.
- History of hepatitis or jaundice associated with prior macrolide use.
- Severe hepatic impairment.
Possible side effect
Most side effects are mild to moderate and transient. Common adverse reactions include:
- Gastrointestinal: nausea, abdominal pain, diarrhea, vomiting, dyspepsia.
- Dermatological: rash, pruritus.
- Hepatic: transient elevations in liver enzymes.
- Neurological: headache, dizziness.
Less frequently reported:
- Oral or vaginal candidiasis.
- Taste perversion.
- Hearing loss (usually reversible upon discontinuation).
Serious but rare side effects include hepatitis, anaphylaxis, and QT interval prolongation. Patients should seek medical attention if severe diarrhea, jaundice, palpitations, or signs of hypersensitivity occur.
Drug interaction
Rulide may interact with several medications due to its metabolism via cytochrome P450 3A4:
- Contraindicated: Ergot alkaloids (e.g., ergotamine), terfenadine, astemizole—risk of severe cardiotoxicity.
- Significant interactions:
- Anticoagulants (e.g., warfarin): may potentiate effect; monitor INR.
- Cyclosporine, tacrolimus: increased levels of these immunosuppressants.
- Theophylline: may increase theophylline concentrations.
- Digoxin: potential for increased digoxin levels.
- Statins metabolized by CYP3A4 (e.g., simvastatin, atorvastatin): increased risk of myopathy.
- Midazolam, triazolam: increased sedative effect.
- Less significant: Potential interaction with oral contraceptives; advise backup contraception.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. In that case, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, and abdominal pain. There is no specific antidote. Management is supportive and symptomatic, including gastric lavage if ingestion was recent. Monitor cardiac function due to potential QT prolongation. Hemodialysis is not effective for removal.
Storage
Store at room temperature (15–30°C), in the original container, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for healthcare professionals and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read here. The efficacy and safety profile may vary based on individual patient factors and local prescribing information.
Reviews
Rulide has been extensively reviewed in clinical literature and is regarded as an effective and well-tolerated antibiotic. In meta-analyses, it demonstrates comparable efficacy to other macrolides and some beta-lactams in respiratory infections, with a lower discontinuation rate due to adverse events than erythromycin. Patient reviews often highlight the convenience of dosing and minimal gastrointestinal upset. However, as with all antibiotics, appropriate use within antimicrobial stewardship guidelines is emphasized to preserve its utility.